CYP3A4 and benign prostatic hyperplasia: The results of this study showed that BPH patients who subsequently developed PRCa have significantly different frequency of harbouring CYP3A4, and VDR at risk genotypes than those BPH patients who did not develop PRCa (13-fold, Tayeb et al, 2002, submitted).